{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:03:38Z","timestamp":1790129018352,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e01053","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:06:53Z","timestamp":1787814413000},"page":"e01053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting SUV4\u201320H2-mediated H4K20 methylation restrains growth and migration in pediatric high-grade astrocytomas"],"prefix":"10.1016","volume":"23","author":[{"given":"Angeliki-Ioanna","family":"Giannopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Kosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios S.","family":"Kanakoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Klonou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Sarantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mitsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Sgouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Korkolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01053_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/children8090739","article-title":"Classification and treatment of pediatric gliomas in the molecular era","volume":"8","author":"Hauser","year":"2021","journal-title":"Children"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01053_bib2","article-title":"Molecular convergence enables precision medicine for pediatric low grade gliomas","volume":"17","author":"Xu","year":"2026","journal-title":"Discov Oncol"},{"key":"10.1016\/j.neurot.2026.e01053_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-020-00902-z","article-title":"Pediatric low-grade glioma in the era of molecular diagnostics","volume":"8","author":"Ryall","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2026.e01053_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.32074\/1591-951X-830","article-title":"Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO classification","volume":"114","author":"Gianno","year":"2022","journal-title":"Pathologica"},{"key":"10.1016\/j.neurot.2026.e01053_bib5","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s13311-021-01090-x","article-title":"Histone mark profiling in pediatric astrocytomas reveals prognostic significance of H3K9 trimethylation and histone methyltransferase SUV39H1","volume":"18","author":"Klonou","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2026.e01053_bib6","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.04.08","article-title":"Chromatin remodeling defects in pediatric brain tumors","volume":"6","author":"Klonou","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.neurot.2026.e01053_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1243395","article-title":"Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease","volume":"14","author":"Agredo","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.neurot.2026.e01053_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.210377.112","article-title":"Suv4-20h2 mediates chromatin compaction and is important for cohesin recruitment to heterochromatin","volume":"27","author":"Hahn","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.neurot.2026.e01053_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052498","article-title":"Impact of histone lysine methyltransferase SUV4-20H2 on cancer onset and progression with therapeutic potential","volume":"25","author":"Papadaki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01053_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neurot.2026.e01053_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc, Ser B Stat Methodol"},{"key":"10.1016\/j.neurot.2026.e01053_bib12","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.neurot.2026.e01053_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.neurot.2026.e01053_bib15","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e01053_bib16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00109-025-02592-3","article-title":"SUV39H1 regulates progression of pediatric diffuse high-grade gliomas through modulation of \u03b2-catenin\/TCF4 levels","volume":"103","author":"Klonou","year":"2025","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.neurot.2026.e01053_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurot.2026.e01053_bib19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s13311-022-01249-0","article-title":"Major features of the 2021 WHO classification of CNS tumors","volume":"19","author":"Smith","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2026.e01053_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115101","article-title":"Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas: a multivariate analysis including trimethylation of H3K9 and H4K20","volume":"10","author":"Sepsa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01053_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232565","article-title":"An ImageJ plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01053_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00754","article-title":"LINE-1 hypomethylation in cell-free DNA of high-grade glioma patients correlates with tissue levels and is associated with reduced DNMT1 and H4K20me3 expression","volume":"22","author":"Giannopoulou","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2026.e01053_bib23","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/1055-9965.EPI-10-0454","article-title":"Global histone modification patterns as prognostic markers to classify glioma patients","volume":"19","author":"Liu","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.neurot.2026.e01053_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbrc.2023.04.066","article-title":"Epigenetic regulation of DHRS2 by SUV420H2 inhibits cell apoptosis in renal cell carcinoma","volume":"663","author":"Ryu","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurot.2026.e01053_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1083\/jcb.201705031","article-title":"SUV420H2 is an epigenetic regulator of epithelial\/mesenchymal states in pancreatic cancer","volume":"217","author":"Viotti","year":"2018","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neurot.2026.e01053_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/0008-5472.CAN-24-3974","article-title":"Targeting SUV4-20H epigenetic enzymes enhances topoisomerase II poisoning in prostate cancer","volume":"86","author":"Alhourani","year":"2026","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01053_bib27","first-page":"1","article-title":"Impact of histone methyltransferase SUV420H2 in breast cancer","volume":"13","author":"Isin","year":"2020","journal-title":"Biomed Rep"},{"key":"10.1016\/j.neurot.2026.e01053_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2096-x","article-title":"miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2","volume":"10","author":"Wu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neurot.2026.e01053_bib29","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/gkt012","article-title":"Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity","volume":"41","author":"J\u00f8rgensen","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neurot.2026.e01053_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3681","article-title":"Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity","volume":"16","author":"Yokoyama","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01053_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cm.21504","article-title":"Regulating a key mitotic regulator, polo-like kinase 1 (PLK1)","volume":"75","author":"Colicino","year":"2018","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.neurot.2026.e01053_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5483\/BMBRep.2014.47.5.061","article-title":"Polo-like kinase-1 in DNA damage response","volume":"47","author":"Hyun","year":"2014","journal-title":"BMB Rep"},{"key":"10.1016\/j.neurot.2026.e01053_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114747","article-title":"Polo-like kinase 1 (PLK1) signaling in cancer and beyond","volume":"193","author":"Iliaki","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01053_bib34","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1080\/15384101.2017.1363942","article-title":"Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation","volume":"16","author":"Li","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neurot.2026.e01053_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nchembio.2282","article-title":"The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity","volume":"13","author":"Bromberg","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.neurot.2026.e01053_bib36","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.15252\/embj.201796541","article-title":"Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication","volume":"36","author":"Brustel","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.neurot.2026.e01053_bib37","article-title":"A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair","volume":"5","author":"Li","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.neurot.2026.e01053_bib38","article-title":"Therapeutic opportunities for PLK1 inhibitors: spotlight on BRCA1-deficiency and triple negative breast cancers","volume":"821","author":"Garc\u00eda","year":"2020","journal-title":"Mutat Res"},{"key":"10.1016\/j.neurot.2026.e01053_bib39","first-page":"67","article-title":"Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers","volume":"10","author":"Stratmann","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.neurot.2026.e01053_bib40","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-20-1377","article-title":"PLK1 induces chromosomal instability and overrides cell-cycle checkpoints to drive tumorigenesis","volume":"81","author":"Gheghiani","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01053_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12102953","article-title":"The CINs of Polo-Like Kinase 1 in cancer","volume":"12","author":"Cunningham","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neurot.2026.e01053_bib42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.18632\/oncotarget.28456","article-title":"The dark side of PLK1: implications for cancer and genomic instability","volume":"14","author":"Gheghiani","year":"2023","journal-title":"Oncotarget"},{"key":"10.1016\/j.neurot.2026.e01053_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4048\/jbc.2022.25.e28","article-title":"Polo-like kinase 1 regulates chromosomal instability and paclitaxel resistance in breast cancer cells","volume":"25","author":"Quan","year":"2022","journal-title":"J Breast Cancer"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:09:01Z","timestamp":1790125741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926002230"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01053","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SUV4\u201320H2-mediated H4K20 methylation restrains growth and migration in pediatric high-grade astrocytomas","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01053"}}